CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project explores the role of apelin, an angiogenic factor, in cancer progression and treatment. It aims to investigate the effects of apelin inhibition on tumor growth and its potential as a therapeutic target in cancer therapies.
The spread of cancer is a major cause of mortality and morbidity throughout Europe and beyond.
As the growth of solid tumours is dependent on the formation of a neovascular supply, inhibition of tumour-induced neoangiogenesis represents an actively pursued strategy to treat human cancers.
Current anti-angiogenic therapies are, however, hampered by the onset of resistance through upregulation of additional angiogenesis factors.
Therefore, the identification and study of these alternative neo-angi…
INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE GMBH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
